Tabbert T.

Tabbert T. has a diverse work experience in the finance field. They are currently serving as the VP of Finance at Iambic Therapeutics since June 2022.

Prior to that, Tabbert held various roles at Codexis, Inc. Tabbert was the AVP Finance from March 2021 to May 2022. They also served as the Sr. Director of Finance from January 2013 to March 2021, where they dealt with the company's pivot from bio-fuels to pharmaceutical supply and bio-therapeutic asset development. Additionally, Tabbert was the Director of FP&A from December 2012 to December 2013, contributing to the turnaround of the company after it lost its largest customer.

Before joining Codexis, Inc., Tabbert worked at Micrus Endovascular from June 2006 to June 2012. They held the role of Director of Financial Planning and Analysis during this time and played a key role in managing acquisitions and the R&D pipeline. Prior to that, they were the Manager of Financial Planning and Analysis from June 2006 to May 2008 and implemented various financial systems and methodologies.

Tabbert's earlier experience includes roles at Hyperion Solutions from February 2000 to July 2005, where they served as the Director of Operations, APAC and as the APAC Liaison. They were responsible for improving communication and partnership within the APAC region and achieving the company's financial and business goals. They also worked as a Senior Analyst, International, streamlining revenue recognition processes.

Tabbert began their career at Continental Airlines, where they worked as a Senior Analyst in Corporate Development from December 1998 to January 2000 and as an Analyst in Market Planning from August 1997 to November 1998.

Tabbert T. earned a Bachelor of Arts degree in Economics from Tufts University, where they studied from 1989 to 1993. Later, they pursued an MBA at Georgetown University McDonough School of Business from 1995 to 1997.